Found 145 matching trials
Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL PHASE1 Alloimmune-mediated platelet transfusion refractoriness(PTR) was usually ca...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma PHASE1 The purpose of this clinical trial is to learn if allogeneic cord blood-der...
Show More Location
Xi'an No.3 Hospital
Learn More & Join Trial
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease EARLY_PHASE1 This is an exploratory, open-label, single-arm Phase 1 clinical study desig...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy PHASE1 This Phase I study is designed to evaluate the safety and efficacy of FKC28...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT PHASE3 This is a randomised, multicentre, controlled, open-label, Phase III global...
Show More Learn More & Join Trial
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients EARLY_PHASE1 This is an early exploratory phase, single arm, non-randomized, open label,...
Show More Location
Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University
Learn More & Join Trial
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases EARLY_PHASE1 This is a single-arm, open-label, phase I clinical study to evaluate the sa...
Show More Location
Nanjing Children's Hospital
Learn More & Join Trial
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases EARLY_PHASE1 This is an open clinical pharmacological translational Research Study, aimi...
Show More Location
The Third the People's Hospital of Bengbu
Learn More & Join Trial
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Changzhou No.2 People's Hospital
Learn More & Join Trial
RN1201 Injection in the Treatment of Antibody-Mediated Diseases PHASE1 This single-arm, open-label exploratory trial aims to evaluate the safety, ...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial